Ken Griffin Xoma Corp Put Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$19.1 - $26.32 $13,370 - $18,424	-700 Reduced 29.17%	1,700 $40,000
Q4 2023 Feb 14, 2024	SELL	$13.82 - $19.13 $31,786 - $43,999	-2,300 Reduced 48.94%	2,400 $44,000
Q3 2023 Nov 14, 2023	BUY	$14.02 - $17.71 $33,648 - $42,504	2,400 Added 104.35%	4,700 $66,000
Q2 2023 Aug 14, 2023	BUY	$17.0 - $21.58 $27,200 - $34,528	1,600 Added 228.57%	2,300 $43,000
Q1 2023 May 15, 2023	SELL	$18.01 - $23.12 $7,204 - $9,248	-400 Reduced 36.36%	700 $14,000

Q4 2022 Feb 14, 2023	BUY	$16.0 - $25.45 $17,600 - $27,995	1,100 New	1,100 $20,000

6.39M

25.5K

1.7K

Ticker XOMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,450,800
Market Cap $282M
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.